KALV vs. ^GSPC

Last updated Apr 2, 2026

Compare and contrast key facts about KalVista Pharmaceuticals, Inc. (KALV) and S&P 500 Index (^GSPC).

Performance

KALV vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KalVista Pharmaceuticals, Inc. (KALV) and S&P 500 Index (^GSPC). The values are adjusted to include any dividend payments, if applicable.

KALV vs. ^GSPC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
KALV KalVista Pharmaceuticals, Inc.	22.41%	90.67%	-30.86%	81.21%	-48.90%	-30.33%	6.63%	-9.82%	102.56%	37.91%
^GSPC S&P 500 Index	-3.95%	16.39%	23.31%	24.23%	-19.44%	26.89%	16.26%	28.88%	-6.24%	19.42%

Returns By Period

In the year-to-date period, KALV achieves a 22.41% return, which is significantly higher than ^GSPC's -3.95% return. Over the past 10 years, KALV has underperformed ^GSPC with an annualized return of 8.29%, while ^GSPC has yielded a comparatively higher 12.24% annualized return.

KALV

• 1D: -1.79%
• 1M: 23.10%
• YTD: 22.41%
• 6M: 64.07%
• 1Y: 77.23%
• 3Y*: 36.00%
• 5Y*: -6.36%
• 10Y*: 8.29%

^GSPC

• 1D: 0.72%
• 1M: -4.45%
• YTD: -3.95%
• 6M: -2.02%
• 1Y: 16.73%
• 3Y*: 16.96%
• 5Y*: 10.34%
• 10Y*: 12.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

KALV vs. ^GSPC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KALV

KALV Risk / Return Rank: 76
KALV Sharpe Ratio Rank: 78
KALV Sortino Ratio Rank: 78
KALV Omega Ratio Rank: 72
KALV Calmar Ratio Rank: 77
KALV Martin Ratio Rank: 74

^GSPC

^GSPC Risk / Return Rank: 67
^GSPC Sharpe Ratio Rank: 63
^GSPC Sortino Ratio Rank: 64
^GSPC Omega Ratio Rank: 69
^GSPC Calmar Ratio Rank: 60
^GSPC Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KALV vs. ^GSPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KalVista Pharmaceuticals, Inc. (KALV) and S&P 500 Index (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	KALV	^GSPC	Difference
Sharpe ratio Return per unit of total volatility	1.21	0.92	+0.29
Sortino ratio Return per unit of downside risk	2.06	1.41	+0.64
Omega ratio Gain probability vs. loss probability	1.24	1.21	+0.02
Calmar ratio Return relative to maximum drawdown	2.17	1.41	+0.76
Martin ratio Return relative to average drawdown	4.69	6.61	-1.92
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

KALV vs. ^GSPC - Sharpe Ratio Comparison

The current KALV Sharpe Ratio is 1.21, which is higher than the ^GSPC Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of KALV and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	KALV	^GSPC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.21	0.92	+0.29
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.10	0.61	-0.71
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.10	0.68	-0.58
Sharpe Ratio (All Time) Calculated using the full available price history	-0.14	0.46	-0.60

Correlation

The correlation between KALV and ^GSPC is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Drawdowns

KALV vs. ^GSPC - Drawdown Comparison

The maximum KALV drawdown since its inception was -96.68%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for KALV and ^GSPC.

Drawdown Indicators

	KALV	^GSPC	Difference
Max Drawdown Largest peak-to-trough decline	-96.68%	-56.78%	-39.90%
Max Drawdown (1Y) Largest decline over 1 year	-32.79%	-12.14%	-20.65%
Max Drawdown (5Y) Largest decline over 5 years	-85.96%	-25.43%	-60.53%
Max Drawdown (10Y) Largest decline over 10 years	-90.13%	-33.92%	-56.21%
Current Drawdown Current decline from peak	-84.38%	-5.78%	-78.60%
Average Drawdown Average peak-to-trough decline	-85.89%	-10.75%	-75.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.19%	2.60%	+12.59%

Volatility

KALV vs. ^GSPC - Volatility Comparison

KalVista Pharmaceuticals, Inc. (KALV) has a higher volatility of 21.63% compared to S&P 500 Index (^GSPC) at 5.37%. This indicates that KALV's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KALV	^GSPC	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.63%	5.37%	+16.26%
Volatility (6M) Calculated over the trailing 6-month period	44.95%	9.55%	+35.40%
Volatility (1Y) Calculated over the trailing 1-year period	64.52%	18.33%	+46.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	64.52%	16.90%	+47.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	81.28%	18.05%	+63.23%